These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29043608)

  • 1. Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas.
    Darvasi O; Szabo PM; Nemeth K; Szabo K; Spisak S; Liko I; Czirjak S; Racz K; Igaz P; Patocs A; Butz H
    Pathol Oncol Res; 2019 Jan; 25(1):169-182. PubMed ID: 29043608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
    Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
    J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential biomarkers of miRNA in non-functional pituitary adenomas.
    Zhang Q; Wang Y; Zhou Y; Zhang Q; Xu C
    World J Surg Oncol; 2021 Sep; 19(1):270. PubMed ID: 34503538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
    Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
    Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
    He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
    Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
    Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
    Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas.
    Normann KR; Øystese KAB; Berg JP; Lekva T; Berg-Johnsen J; Bollerslev J; Olarescu NC
    Mol Cell Endocrinol; 2016 Dec; 437():183-189. PubMed ID: 27561203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
    Joshi H; Vastrad B; Vastrad C
    J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
    Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
    J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
    Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
    Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and Target Genes in Pituitary Adenomas.
    Feng Y; Mao ZG; Wang X; Du Q; Jian M; Zhu D; Xiao Z; Wang HJ; Zhu YH
    Horm Metab Res; 2018 Mar; 50(3):179-192. PubMed ID: 29351706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry.
    Hattori Y; Ishii H; Tahara S; Morita A; Ozawa H
    Life Sci; 2020 Nov; 260():118416. PubMed ID: 32926922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis.
    Chen Y; Gelfond JA; McManus LM; Shireman PK
    BMC Genomics; 2009 Aug; 10():407. PubMed ID: 19715577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
    Morris DG; Musat M; Czirják S; Hanzély Z; Lillington DM; Korbonits M; Grossman AB
    Eur J Endocrinol; 2005 Jul; 153(1):143-51. PubMed ID: 15994756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays.
    Jang JS; Simon VA; Feddersen RM; Rakhshan F; Schultz DA; Zschunke MA; Lingle WL; Kolbert CP; Jen J
    BMC Genomics; 2011 Mar; 12():144. PubMed ID: 21388556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in non-functioning pituitary adenomas.
    Taniguchi-Ponciano K; Gomez-Apo E; Chavez-Macias L; Vargas G; Espinosa-Cardenas E; Ramirez-Renteria C; Ferreira-Hermosillo A; Sosa E; Silva-Román G; Peña-Martínez E; Andonegui-Elguera S; Vargas-Chavez S; Santiago-Andres Y; Peralta R; Marrero-Rodríguez D; Mercado M
    Cancer Biomark; 2020; 28(2):193-199. PubMed ID: 32224525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.